Focus Stocks

Hewlett Packard (HPQ)

Hewlett Packard (HPQ)


Dell (DELL)

Dell (DELL)


Facebook (FB)

Facebook (FB)


Apple (AAPL)

Apple (AAPL)


Goldman Sachs (GS)

Goldman Sachs (GS)


Featured Stories

Fred's First Quarter 2012 EPS Increase 17%

Fred's First Quarter 2012 EPS Increase 17%


Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook

Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook


Best ETFs For Facebook Exposure

Best ETFs For Facebook Exposure


McDonald's Announces Quarterly Cash Dividend

McDonald's Announces Quarterly Cash Dividend


Is KB HOME Closing in to Resistance?

Is KB HOME Closing in to Resistance?


Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast


SAN FRANCISCO, Feb. 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to discuss fourth quarter and full year 2011 financial results, as well as provide a general business overview, on Wednesday, February 22, 2012, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).  Financial results for the fourth quarter and full year ended December 31, 2011 will be released after market closes on February 22, 2012.

Interested parties may access a live webcast of the teleconference on the company's website at:

http://www.onyx-pharm.com/investors/event-calendar

or by dialing 847-585-4405 and using the passcode 31754065#.  A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 31754065# approximately one hour after the teleconference concludes.  The replay will be available through March 7, 2012. 

About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

SOURCE Onyx Pharmaceuticals, Inc.



Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits. Try it FREE!

TradersHuddle Search

Sponsored By:

Stock Search:


Site Search:

Loading

Stock Market

Loading
Chart
o Dow Jones 12,529.75 ▲33.60 (0.27%)
o S&P 500 1,320.68 ▲1.82 (0.14%)
o NASDAQ 2,839.38 ▼10.74 (-0.38%)
INDEXDJX:.DJI

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)
INDEXSP:.INX

S&P 500

Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)
INDEXNASDAQ:.IXIC

NASDAQ

Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)
Copyright © 2011 TradersHuddle.com. All Rights Reserved.